Open access
Oct 2026
MSRB3 promotes gastric cancer progression and immunotherapy resistance by stabilizing GPX4 to inhibit ferroptosis
MSRB3 is overexpressed and predicts poor prognosis in gastric cancer and targeting MSRB3 enhances response to anti-PD-1 immunotherapy.
Jian-Qin Lai, Tai-Wei Mo, Jin-Xuan Su et al.
· Translational Oncology · 0 citations